Tissue distribution, ontogeny, and chemical induction of aldo-keto reductases in mices

Drug Metabolism and Disposition

Volumn 41, Issue 8, 2013, Pages 1480-1487

  Pratt Hyatt, Matthew ^a   Lickteig, Andrew J ^a   Klaassen, Curtis D ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDO KETO REDUCTASE; ALDO KETO REDUCTASE 1A4; ALDO KETO REDUCTASE 1B3; ALDO KETO REDUCTASE 1B7; ALDO KETO REDUCTASE 1B8; ALDO KETO REDUCTASE 1C12; ALDO KETO REDUCTASE 1C13; ALDO KETO REDUCTASE 1C14; ALDO KETO REDUCTASE 1C18; ALDO KETO REDUCTASE 1C19; ALDO KETO REDUCTASE 1C20; ALDO KETO REDUCTASE 1C21; ALDO KETO REDUCTASE 1C22; ALDO KETO REDUCTASE 1C6; ALDO KETO REDUCTASE 1D1; ALDO KETO REDUCTASE 1E1; ALDO KETO REDUCTASE 7A5; CONSTITUTIVE ANDROSTANE RECEPTOR; MESSENGER RNA; OXIDOREDUCTASE; PREGNANE X RECEPTOR; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME LOCALIZATION; FEMALE; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; ONTOGENY; OVARY; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE; TESTIS; TISSUE DISTRIBUTION;

AGE FACTORS; ALCOHOL OXIDOREDUCTASES; ANIMALS; BRAIN; ENZYME INDUCTION; FEMALE; GENE DOSAGE; KIDNEY; LIVER; MALE; MICE; MICE, INBRED C57BL; NF-E2-RELATED FACTOR 2; TISSUE DISTRIBUTION;

EID: 84880660487     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.113.051904     Document Type: Article

References (53)

1. Aleksunes LM and Klaassen CD (2012) Coordinated regulation of hepatic phase I and II drugmetabolizing genes and transporters using AhR-, CAR-, PXR-, PPARa-, and Nrf2-null mice. Drug Metab Dispos 40:1366-1379.
2. Barski OA, Tipparaju SM, and Bhatnagar A (2009) Kinetics of nucleotide binding to the betasubunit (AKR6A2) of the voltage-gated potassium (Kv) channel. Chem Biol Interact 178: 165-170.
3. Bellemare V, Faucher F, Breton R, and Luu-The V (2005) Characterization of 17alphahydroxysteroid dehydrogenase activity (17alpha-HSD) and its involvement in the biosynthesis of epitestosterone. BMC Biochem 6:12 DOI: 10.1186/1471-2091-6-12.
4. Chan K, Lu R, Chang JC, and Kan YW (1996) NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci USA 93:13943-13948.
5. Cheng X, Maher J, Dieter MZ, and Klaassen CD (2005) Regulation of mouse organic aniontransporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways. Drug Metab Dispos 33:1276-1282.
6. Cui JY, Gunewardena SS, Yoo B, Liu J, Renaud HJ, Lu H, Zhong XB, and Klaassen CD (2012a) RNA-Seq reveals different mRNA abundance of transporters and their alternative transcript isoforms during liver development. Toxicol Sci 127:592-608.
7. Cui JY, Renaud HJ, and Klaassen CD (2012b) Ontogeny of novel cytochrome P450 gene isoforms during postnatal liver maturation in mice. Drug Metab Dispos 40:1226-1237.
8. Deyashiki Y, Ohshima K, Nakanishi M, Sato K, Matsuura K, and Hara A (1995) Molecular cloning and characterization of mouse estradiol 17 beta-dehydrogenase (A-specific), a member of the aldoketoreductase family. J Biol Chem 270:10461-10467.
9. Dhagat U, Endo S, Hara A, and El-Kabbani O (2008) Inhibition of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) by aldose reductase inhibitors. Bioorg Med Chem 16:3245-3254.
10. Du Y, Tsai S, Keller JR, and Williams SC (2000) Identification of an interleukin-3-regulated aldoketo reductase gene in myeloid cells which may function in autocrine regulation of myelopoiesis. J Biol Chem 275:6724-6732.
11. Dufort I, Soucy P, Labrie F, and Luu-The V (1996) Molecular cloning of human type 3 3 alphahydroxysteroid dehydrogenase that differs from 20 alpha-hydroxysteroid dehydrogenase by seven amino acids. Biochem Biophys Res Commun 228:474-479.
12. Ellis EM, Judah DJ, Neal GE, and Hayes JD (1993) An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases. Proc Natl Acad Sci USA 90:10350-10354.
13. Endo S, Matsumoto K, Matsunaga T, Ishikura S, Tajima K, El-Kabbani O, and Hara A (2006) Substrate specificity of a mouse aldo-keto reductase (AKR1C12). Biol Pharm Bull 29: 2488-2492.
14. Endo S, Sanai M, Horie K, Matsunaga T, Ishikura S, Tajima K, El-Kabbani O, and Hara A (2007) Characterization of rat and mouse NAD+-dependent 3alpha/17beta/20alpha-hydroxysteroid dehydrogenases and identification of substrate specificity determinants by site-directed mutagenesis. Arch Biochem Biophys 467:76-86.
15. Gonzales E, Cresteil D, Baussan C, Dabadie A, Gerhardt MF, and Jacquemin E (2004) SRD5B1 (AKR1D1) gene analysis in delta(4)-3-oxosteroid 5beta-reductase deficiency: evidence for primary genetic defect. J Hepatol 40:716-718.
16. Guengerich FP and Johnson WW (1999) Kinetics of hydrolysis and reaction of aflatoxin B1 exo-8,9-epoxide and relevance to toxicity and detoxication. Drug Metab Rev 31:141-158.
17. Hart SN, Cui Y, Klaassen CD, and Zhong XB (2009) Three patterns of cytochrome P450 gene expression during liver maturation in mice. Drug Metab Dispos 37:116-121.
18. Hinshelwood A, McGarvie G, and Ellis E (2002) Characterisation of a novel mouse liver aldoketo reductase AKR7A5. FEBS Lett 523:213-218.
19. Hoog SS, Pawlowski JE, Alzari PM, Penning TM, and Lewis M (1994) Three-dimensional structure of rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldoketo reductase superfamily. Proc Natl Acad Sci USA 91:2517-2521.
20. Hyndman D, Bauman DR, Heredia VV, and Penning TM (2003) The aldo-keto reductase superfamily homepage. Chem Biol Interact 143-144:621-631.
21. Ishikura S, Horie K, Sanai M, Matsumoto K, and Hara A (2005) Enzymatic properties of a member (AKR1C19) of the aldo-keto reductase family. Biol Pharm Bull 28:1075-1078.
22. Ishikura S, Usami N, Nakajima S, Kameyama A, Shiraishi H, Carbone V, El-Kabbani O, and Hara A (2004) Characterization of two isoforms of mouse 3(17)alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase family. Biol Pharm Bull 27:1939-1945.
23. Jez JM, Bennett MJ, Schlegel BP, Lewis M, and Penning TM (1997) Comparative anatomy of the aldo-keto reductase superfamily. Biochem J 326:625-636.
24. Jin Y and Penning TM (2007) Aldo-keto reductases and bioactivation/ detoxication. Annu Rev Pharmacol Toxicol 47:263-292.
25. Kabututu Z, Manin M, Pointud JC, Maruyama T, Nagata N, Lambert S, Lefrançois-Martinez AM, Martinez A, and Urade Y (2009) Prostaglandin F2alpha synthase activities of aldo-keto reductase 1B1, 1B3 and 1B7. J Biochem 145:161-168.
26. Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T, Igarashi K, and Yamamoto M (2004) Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 24:7130-7139.
27. Kodama S, Hosseinpour F, Goldstein JA, and Negishi M (2011) Liganded pregnane X receptor represses the human sulfotransferase SULT1E1 promoter through disrupting its chromatin structure. Nucleic Acids Res 39:8392-8403.
28. Kondo KH, Kai MH, Setoguchi Y, Eggertsen G, Sjöblom P, Setoguchi T, Okuda KI, and Björkhem I (1994) Cloning and expression of cDNA of human delta 4-3-oxosteroid 5 betareductase and substrate specificity of the expressed enzyme. Eur J Biochem 219:357-363.
29. Lau ET, Cao D, Lin C, Chung SK, and Chung SS (1995) Tissue-specific expression of two aldose reductase-like genes in mice: abundant expression of mouse vas deferens protein and fibroblast growth factor-regulated protein in the adrenal gland. Biochem J 312:609-615.
30. Liu MJ, Takahashi Y, Wada T, He J, Gao J, Tian Y, Li S, and Xie W (2009) The aldo-keto reductase Akr1b7 gene is a common transcriptional target of xenobiotic receptors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol 76:604-611.
31. Lu H, Cui JY, Gunewardena S, Yoo B, Zhong XB, and Klaassen CD (2012) Hepatic ontogeny and tissue distribution of mRNAs of epigenetic modifiers in mice using RNA-sequencing. Epigenetics 7:914-929.
32. Mao J, Duan RW, Zhong L, Gibori G, and Azhar S (1997) Expression, purification and characterization of the rat luteal 20 alpha-hydroxysteroid dehydrogenase. Endocrinology 138: 182-190.
33. Matsumoto K, Endo S, Ishikura S, Matsunaga T, Tajima K, El-Kabbani O, and Hara A (2006) Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. Biol Pharm Bull 29:539-542.
34. McCormack T and McCormack K (1994) Shaker K+ channel beta subunits belong to an NAD(P) H-dependent oxidoreductase superfamily. Cell 79:1133-1135.
35. Mindnich R, Drury JE, and Penning TM (2011) The effect of disease associated point mutations on 5b-reductase (AKR1D1) enzyme function. Chem Biol Interact 191:250-254.
36. Okada K, Shoda J, Taguchi K, Maher JM, Ishizaki K, Inoue Y, Ohtsuki M, Goto N, Takeda K, and Utsunomiya H, et al. (2008) Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. Am J Physiol Gastrointest Liver Physiol 295:G735-G747.
37. Pan Y, Weng J, Kabaleeswaran V, Li H, Cao Y, Bhosle RC, and Zhou M (2008) Cortisone dissociates the Shaker family K+ channels from their beta subunits. Nat Chem Biol 4:708-714.
38. Penning TM, Burczynski ME, Hung CF, McCoull KD, Palackal NT, and Tsuruda LS (1999) Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones. Chem Res Toxicol 12:1-18.
39. Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, Moore M, Palackal N, and Ratnam K (2000) Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 351:67-77.
40. Penning TM, Ohnishi ST, Ohnishi T, and Harvey RG (1996) Generation of reactive oxygen species during the enzymatic oxidation of polycyclic aromatic hydrocarbon trans-dihydrodiols catalyzed by dihydrodiol dehydrogenase. Chem Res Toxicol 9:84-92.
41. Rheault P, Charbonneau A, and Luu-The V (1999) Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). Biochim Biophys Acta 1447:17-24.
42. Sakuma M and Kubota S (2008) Mouse AKR1E1 is an ortholog of pig liver NADPH dependent 1,5-Anhydro-D-fructose reductase. Biosci Biotechnol Biochem 72:872-876.
43. Salabei JK, Li XP, Petrash JM, Bhatnagar A, and Barski OA (2011) Functional expression of novel human and murine AKR1B genes. Chem Biol Interact 191:177-184.
44. Schmidt DR, Schmidt S, Holmstrom SR, Makishima M, Yu RT, Cummins CL, Mangelsdorf DJ, and Kliewer SA (2011) AKR1B7 is induced by the farnesoid X receptor and metabolizes bile acids. J Biol Chem 286:2425-2432.
45. Seery LT, Nestor PV, and FitzGerald GA (1998) Molecular evolution of the aldo-keto reductase gene superfamily. J Mol Evol 46:139-146.
46. Spite M, Baba SP, Ahmed Y, Barski OA, Nijhawan K, Petrash JM, Bhatnagar A, and Srivastava S (2007) Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. Biochem J 405:95-105.
47. Stolz A, Sugiyama Y, Kuhlenkamp J, and Kaplowitz N (1984) Identification and purification of a 36 kDa bile acid binder in human hepatic cytosol. FEBS Lett 177:31-35.
48. Takahashi M, Miyata S, Fujii J, Inai Y, Ueyama S, Araki M, Soga T, Fujinawa R, Nishitani C, and Ariki S, et al. (2012) In vivo role of aldehyde reductase. Biochim Biophys Acta 1820: 1787-1796.
49. Usami N, Kitahara K, Ishikura S, Nagano M, Sakai S, and Hara A (2001) Characterization of a major form of human isatin reductase and the reduced metabolite. Eur J Biochem 268: 5755-5763.
50. Veliça P, Davies NJ, Rocha PP, Schrewe H, Ride JP, and Bunce CM (2009) Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers. Mol Cancer 8:121 DOI: 10.1186/1476-4598-8-121.
51. Vergnes L, Phan J, Stolz A, and Reue K (2003) A cluster of eight hydroxysteroid dehydrogenase genes belonging to the aldo-keto reductase supergene family on mouse chromosome 13. J Lipid Res 44:503-511.
52. Wu KC, Cui JY, and Klaassen CD (2011) Beneficial role of Nrf2 in regulating NADPH generation and consumption. Toxicol Sci 123:590-600.
53. Xie Z, Barski OA, Cai J, Bhatnagar A, and Tipparaju SM (2011) Catalytic reduction of carbonyl groups in oxidized PAPC by Kvb2 (AKR6). Chem Biol Interact 191:255-260.